Tokyo, April 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061385) titled 'A Study on Minimizing Blood Transfusion Volume by Suppressing Blood Diluti... Read More
Tokyo, April 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061384) titled 'Yoga Therapy Intervention for Individuals with Alcohol Use Disorder: A Sin... Read More
Tokyo, April 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061381) titled 'Acute effects of blood flow restriction-augmented passive manual therapy o... Read More
Tokyo, April 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061378) titled 'A Study of a New Three-Dimensional Method to Measure Hand and Finger Movem... Read More
Tokyo, April 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061368) titled 'Study on the effect of different evaluation environments on subjective eva... Read More
Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ISRCTN90722773) titled 'Promoting respectful maternity care in China' on April 27. Study Type: Inter... Read More
Singapore, April 26 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 26 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 26 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More
Singapore, April 26 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More